It might be explained by the fact that the levels of sHLA-G in glioma patients are influenced not only by HLA-G variants, but also by environmental factors, such as treatment, hormones, stress, and hypoxia [70,71]. This evidence concerns the gene HLA-G and central nervous system cancer.